Roles of elevated intravitreal IL-1β and IL-10 levels in proliferative diabetic retinopathy

Indian Journal of Ophthalmology

Volumn 62, Issue 6, 2014, Pages 699-701

  Mao, Chunjie ^a   Yan, Hua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic retinopathy; enzyme linked immunosorbent assay; immunology; interleukin 10; interleukin 1 ; proliferative

Indexed keywords

IL10 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 1BETA;

ADOLESCENT; ADULT; AGED; CHILD; COMPLICATION; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MALE; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY; YOUNG ADULT;

EID: 84905646693     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.136220     Document Type: Article

References (19)

1. Abu El Asar AM, Al Mezaine HS, Ola MS. Pathophysiology and management of diabetic retinopathy. Exp Rev Opthalmol 2009;4:627-47.
2. Kowluru RA, Odenbach S. Role of interleukin 1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol 2004:88:1343-7.
3. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007;2007:95103.
4. Koskela UE, Kuusisto SM, Nissinen AE, Savolainen MJ, Liinamaa MJ. High vitreous concentration of IL 6 and IL 8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy. Ophthalmic Res 2013:49:108-14.
5. Kim SJ, Kim S, Park J, Lee HK, Park KS, Yu HG, et al. Differential expression of vitreous proteins in proliferative diabetic retinopathy. Curr Eye Res 2006;31:231-40.
6. Hernández C, Segura RM, Fonollosa A, Carrasco E, Francisco G, Simó R. Interleukin 8, monocyte chemoattractant protein 1 and IL 10 in the vitreous fluid of patients with proliferative diabetic retinopathy. Diabetic Med 2005;22:719-22.
7. Murugeswari P, Shukla D, Rajendran A, Kim R, Namperumalsamy P, Muthukkaruppan V. Proinflammatory cytokines and angiogenic and anti angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and ealeś disease. Retina 2008;28:817-24.
8. Adamiec Mroczek J, Oficjalska Mlynczak J, Misiuk Hojlo M. Roles of endothelin 1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples. Cytokine. 2010:49:269-74.
9. Koleva Georgieva DN, Sivkova NP, Terzieva D. Serum inflammatory cytokines IL 1beta, IL 6, TNF alpha and VEGF have influence on the development of diabetic retinopathy. Folia Med (Plovdiv) 2011:53:44-50.
10. Lee JH, Lee W, Kwon OH, Kim JH, Kwon OW, Kim KH, et al. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy. Ann Clin Lab Sci 2008:38:361-7.
11. El Ghrably IA, Dua HS, Orr GM, Fisher D, Tighe PJ. Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy. Br J Ophthalmol 2001:85:461-70.
12. Vincent JA, Mohr S. Inhibition of caspase 1/interleukin 1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes 2007:56:224-30.
13. Kowluru RA, Odenbach S. Role of interleukin 1beta in the development of retinopathy in rats: Effect of antioxidants. Invest Ophthalmol Vis Sci 2004;45:4161-6.
14. Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase 3 activation in a rodent model of diabetic retinopathy. Diabetes 2005:54:1559-65.
15. Zhou J, Wang S, Xia X. Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy. Curr Eye Res 2012:37:416-20.
16. Paine SK, Sen A, Choudhuri S, Mondal LK, Chowdhury IH, Basu A, et al. Association of tumor necrosis factor α, interleukin 6, and interleukin 10 promoter polymorphism with proliferative diabetic retinopathy in type 2 diabetic subjects. Retina 2012:32:1197-203.
17. Hernández C, Segura RM, Fonollosa A, Carrasco E, Francisco G, Simó R. Interleukin 8, monocyte chemoattractant protein 1 and IL 10 in the vitreous fluid of patients with proliferative diabetic retinopathy. Diabet Med 2005:22:719-22.
18. Myśliwiec M, Zorena K, Balcerska A, Myśliwska J, Lipowski P, Raczyńska K. The activity of N acetyl beta D glucosaminidase and tumor necrosis factor alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children. Clin Biochem 2006:39:851-6.
19. Canataroglu H, Varinli I, Ozcan AA, Canataroglu A, Doran F, Varinli S. Interleukin (IL) 6, interleukin (IL) 8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy. Ocul Immunol Inflamm 2005:13:375-81